said George Morrow, co-president of U.S. pharmaceutical operations, resigned to take a position with another company, effective Jan. 19.
The British pharmaceutical giant said David Stout, 46, who headed
North American pharmaceutical operations before it merged with
, will assume Morrow's duties. Before joining SmithKline Beecham, Stout was president of
GlaxoSmithKline's shares lately dipped 25 cents, or 0.5%, to $51.88 on the
New York Stock Exchange